Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17159545rdf:typepubmed:Citationlld:pubmed
pubmed-article:17159545lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0026032lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0879626lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C1273870lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:17159545lifeskim:mentionsumls-concept:C0303596lld:lifeskim
pubmed-article:17159545pubmed:issue1lld:pubmed
pubmed-article:17159545pubmed:dateCreated2006-12-12lld:pubmed
pubmed-article:17159545pubmed:abstractTextSelective internal radiation therapy with 90Y microspheres (SIR spheres) is increasingly used in the treatment of extensive liver tumours. Careful selection and preparation of patients are necessary to avoid possible adverse effects. We aimed to evaluate the incidence and severity of adverse effects resulting from the administration of SIR spheres during therapy.lld:pubmed
pubmed-article:17159545pubmed:languageenglld:pubmed
pubmed-article:17159545pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17159545pubmed:citationSubsetIMlld:pubmed
pubmed-article:17159545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17159545pubmed:statusMEDLINElld:pubmed
pubmed-article:17159545pubmed:monthJanlld:pubmed
pubmed-article:17159545pubmed:issn0143-3636lld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:StammDDlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:BansiDDlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:RubelloDDlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:O'RourkeEElld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:Thillainayaga...lld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:NijranKKlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:WasanHarpreet...lld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:HabibNagyNlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:Al-NahhasAdil...lld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:CaneloRubenRlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:TaitPaulPlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:JiaoLongLlld:pubmed
pubmed-article:17159545pubmed:authorpubmed-author:SzyszkoTeresa...lld:pubmed
pubmed-article:17159545pubmed:issnTypePrintlld:pubmed
pubmed-article:17159545pubmed:volume28lld:pubmed
pubmed-article:17159545pubmed:ownerNLMlld:pubmed
pubmed-article:17159545pubmed:authorsCompleteYlld:pubmed
pubmed-article:17159545pubmed:pagination21-4lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:meshHeadingpubmed-meshheading:17159545...lld:pubmed
pubmed-article:17159545pubmed:year2007lld:pubmed
pubmed-article:17159545pubmed:articleTitleManagement and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres.lld:pubmed
pubmed-article:17159545pubmed:affiliationDepartment of Nuclear Medicine, S. Maria della Misericordia Hospital, Rovigo, Italy.lld:pubmed
pubmed-article:17159545pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17159545lld:pubmed